DxNA
FDA Clears DxNA's Valley Fever Molecular Test
The test runs on the GeneSTAT system, and has demonstrated 100 percent sensitivity, 99.6 percent specificity, and 100 percent reproducibility.
DxNA Files for FDA Clearance of MDx System, Valley Fever Assay
The firm's real-time PCR-based GeneStat system was developed leveraging IP licensed exclusively from the Translational Genomics Research Institute.